Diquafosol eye drops for moderate-to-severe eye allergy
Part of Eyes & vision, Immune system & allergy clinical trials.
This trial tests a new eye drop called diquafosol for people with a severe, active eye allergy called vernal keratoconjunctivitis. It aims to see if the drops can calm the allergy and help heal the surface of the eye.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 6 years old or older.
- You have been diagnosed with vernal keratoconjunctivitis (a severe eye allergy).
- Your eye allergy is currently moderate to severe.
- You have damage to the surface of your eye (cornea) from the allergy.
- You have had at least one flare-up of this eye allergy in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tacrolimus eye drops can reduce the symptoms of vernal keratoconjunctivitis (a severe eye allergy) in children aged 5 to 15. If effective, the treatment could provide a new option to control this uncomfortable condition.
This study tests a new eye drop (T1695) against cyclosporine for children with moderate to severe vernal keratoconjunctivitis, a type of eye allergy. It aims to see which treatment works better and is safer for reducing symptoms.
This trial tests a new eye drop to reduce itching and other symptoms of allergic conjunctivitis, a condition where the eyes become red, itchy, and uncomfortable due to allergies. It may help people who have not found relief with current treatments.
This study compares two different eye drops to see which works better for people who still have dry eye symptoms at least six months after LASIK surgery. The goal is to find a more effective treatment to relieve discomfort and improve eye health.
This trial tests an eye drop called Daydrop Triple Action to see if it helps with eye itching and redness caused by allergies. It might be a good option if you have allergic conjunctivitis and have not used other allergy eye medications recently.
This trial tests a new eye drop (0.4% solution) to see if it's safe and effective for people with dry eye. It's for both contact lens wearers and non-wearers who have dry eye symptoms, and aims to find a better way to relieve discomfort.
Hear when a new Vernal Keratoconjunctivitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.